Source: The Business Journals: Raleigh/Durham

Altavant Sciences: Cary drugmaker makes first acquisition with new financial backing

A Triangle drugmaker starting the year with a fresh financial backer has made an acquisition of its own.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Bill Symonds's photo - CEO of Altavant Sciences

CEO

Bill Symonds

CEO Approval Rating

90/100

Altavant Sciences is a biopharmaceutical company that develops and commercializes drug-based therapy for the treatment of respiratory diseases. Read more